The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122702492 12270249 2 F 20160722 20160415 20160728 EXP PL-ROCHE-1740633 ROCHE 25.00 YR F Y 0.00000 20160728 MD PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122702492 12270249 1 PS Omalizumab OMALIZUMAB 1 Subcutaneous N 103976 SOLUTION FOR INJECTION QOW
122702492 12270249 2 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 16 MG, QD N 0 16 MG QD
122702492 12270249 3 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown DECREASED DOSE N 0 6 MG QD
122702492 12270249 4 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 32 MG, QD N 0 32 MG QD
122702492 12270249 5 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 16 MG, QD N 0 16 MG QD
122702492 12270249 6 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 4 MG, QD N 0 4 MG QD
122702492 12270249 7 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 6 MG, QD N 0 6 MG QD
122702492 12270249 8 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 8 MG, QD N 0 8 MG QD
122702492 12270249 9 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown 16 MG, QD N 0 16 MG QD
122702492 12270249 10 C CICLESONIDE CICLESONIDE 1 Unknown 1280 MG, QD 0 1280 MG QD
122702492 12270249 11 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 Unknown 0
122702492 12270249 12 C SALBUTAMOL ALBUTEROL 1 Unknown 2 DF, QD U 0 2 DF QD
122702492 12270249 13 C TIOTROPIUM TIOTROPIUM 1 Unknown U 0
122702492 12270249 14 C BUDESONIDE. BUDESONIDE 1 Unknown 1 G, TID U 0 1 G TID
122702492 12270249 15 C LORATADINE. LORATADINE 1 Unknown U 0
122702492 12270249 16 C AZELASTINE AZELASTINE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122702492 12270249 1 Asthma
122702492 12270249 2 Asthma
122702492 12270249 10 Product used for unknown indication
122702492 12270249 11 Product used for unknown indication
122702492 12270249 12 Product used for unknown indication
122702492 12270249 13 Product used for unknown indication
122702492 12270249 14 Product used for unknown indication
122702492 12270249 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122702492 12270249 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122702492 12270249 Asthma
122702492 12270249 Cough
122702492 12270249 Dyspnoea exertional
122702492 12270249 Febrile infection
122702492 12270249 Infection
122702492 12270249 Maternal exposure during pregnancy
122702492 12270249 Nasal obstruction
122702492 12270249 Rales
122702492 12270249 Rhinitis
122702492 12270249 Sinusitis
122702492 12270249 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122702492 12270249 1 20150112 0